Gastric Schwannoma: A Tumor Must Be Included in Differential Diagnoses of Gastric Submucosal Tumors

Table 1

Clinical features of GS reported in English literature.

	Benign	Malignant	Overall	value
Total	211	10	221
Male/female	63/148	5/5	68/153	0.178
Average age (years)	57.13 ± 13.12	49.78 ± 22.44	56.82 ± 13.77	0.118
Symptoms (cases)				0.695
NA	56	1	57 (34.76%)
Multiple symptoms	19	3	22 (13.41%)
Asymptomatic (incidentally found)	69	2	71 (43.29%)
Abdominal pain or discomfort	32	2	34 (20.73%)
GI bleeding	19	2	21 (12.80%)
Palpable mass	5	0	5 (3.05%)
Poor appetite	5	0	5 (3.05%)
Dyspepsia	3	0	3 (1.82%)
Weight loss	2	0	2 (1.22%)
Nausea or vomiting	1	0	1 (0.6%)
Location (cases)				0.581
NA	83	3	86 (52.44%)
Subcardia	2	0	2 (1.22%)
Fundus	15	0	15 (9.15%)
Body	82	5	87 (53.05%)
Antrum	29	2	31 (18.90%)
Size (diameter, cm)				0.897
Mean size	4.66 ± 2.62	4.66 ± 1.97	4.67 ± 2.60
Median size	4	4	4
Follow-up time (months)				0.102
Mean time	78.19 ± 84.85	44.67 ± 38.02	74.67 ± 82.59
Median time	43	28	38.5

NA: not available.